LITTLE FALLS, N.J.--(BUSINESS WIRE)--CANTEL MEDICAL CORP. (NYSE:CMN) reported income from continuing operations of $2,230,000, or $0.14 per diluted share (inclusive of $0.02 of net expense for stock-based compensation), on a 16% increase in sales to $54,412,000 for its third quarter ended April 30, 2007. This compares with income from continuing operations of $1,639,000, or $0.10 per diluted share (inclusive of $0.01 of net expense for stock-based compensation), on sales of $46,887,000 for the third quarter ended April 30, 2006. For the nine months ended April 30, 2007, the Company reported income from continuing operations of $6,205,000, or $0.39 per diluted share, on a 10% increase in sales to $156,531,000. This compares with income from continuing operations of $5,731,000, or $0.35 per diluted share, on sales of $142,039,000 for the nine months ended April 30, 2006. Net expense for stock-based compensation for the nine months ended April 30, 2007 was comparable to the prior year period.
